
Ardin H. Marschel
Examiner (ID: 15670)
| Most Active Art Unit | 1631 |
| Art Unit(s) | 1634, 1635, 1655, 1744, 1614, 1803, 1631, 1637, 1636, 2899, 1809, 1611, 1807 |
| Total Applications | 1516 |
| Issued Applications | 761 |
| Pending Applications | 308 |
| Abandoned Applications | 447 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19745636
[patent_doc_number] => 20250034201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => PRODRUGS OF GANAXOLONE
[patent_app_type] => utility
[patent_app_number] => 18/825194
[patent_app_country] => US
[patent_app_date] => 2024-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18825194
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/825194 | PRODRUGS OF GANAXOLONE | Sep 4, 2024 | Pending |
Array
(
[id] => 19359212
[patent_doc_number] => 20240261246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => USE OF SMALL MOLECULE COMPOUND AND LENALIDOMIDE IN PREPARATION OF DRUG FOR TREATING MULTIPLE MYELOMA
[patent_app_type] => utility
[patent_app_number] => 18/638894
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18638894
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/638894 | USE OF SMALL MOLECULE COMPOUND AND LENALIDOMIDE IN PREPARATION OF DRUG FOR TREATING MULTIPLE MYELOMA | Apr 17, 2024 | Pending |
Array
(
[id] => 20743963
[patent_doc_number] => 12643854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-02
[patent_title] => Process for preparing a crystalline form of fluvastatin sodium salt
[patent_app_type] => utility
[patent_app_number] => 18/603896
[patent_app_country] => US
[patent_app_date] => 2024-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18603896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/603896 | Process for preparing a crystalline form of fluvastatin sodium salt | Mar 12, 2024 | Issued |
Array
(
[id] => 19402069
[patent_doc_number] => 20240285580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOSITIONS AND METHODS FOR EXTENDED RELEASE CROMAKALIM THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/439552
[patent_app_country] => US
[patent_app_date] => 2024-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18439552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/439552 | COMPOSITIONS AND METHODS FOR EXTENDED RELEASE CROMAKALIM THERAPY | Feb 11, 2024 | Pending |
Array
(
[id] => 19157582
[patent_doc_number] => 20240150289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => CRYSTALLINE CARBAZOLE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/497531
[patent_app_country] => US
[patent_app_date] => 2023-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497531
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/497531 | CRYSTALLINE CARBAZOLE DERIVATIVE | Oct 29, 2023 | Pending |
Array
(
[id] => 19032380
[patent_doc_number] => 20240082195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => COMPOSITIONS FOR TREATING FUNGAL AND BACTERIAL BIOFILMS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/371085
[patent_app_country] => US
[patent_app_date] => 2023-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18371085
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/371085 | COMPOSITIONS FOR TREATING FUNGAL AND BACTERIAL BIOFILMS AND METHODS OF USING THE SAME | Sep 20, 2023 | Pending |
Array
(
[id] => 18902648
[patent_doc_number] => 20240018133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 18/462918
[patent_app_country] => US
[patent_app_date] => 2023-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18462918
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/462918 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Sep 6, 2023 | Pending |
Array
(
[id] => 18844449
[patent_doc_number] => 20230406853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES
[patent_app_type] => utility
[patent_app_number] => 18/242466
[patent_app_country] => US
[patent_app_date] => 2023-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 647
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242466
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/242466 | COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES | Sep 4, 2023 | Pending |
Array
(
[id] => 19158097
[patent_doc_number] => 20240150804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => Demethylation of Reticuline and Derivatives Thereof with Fungal Cytochrome P450
[patent_app_type] => utility
[patent_app_number] => 18/452054
[patent_app_country] => US
[patent_app_date] => 2023-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18452054
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/452054 | Demethylation of Reticuline and Derivatives Thereof with Fungal Cytochrome P450 | Aug 17, 2023 | Pending |
Array
(
[id] => 19263548
[patent_doc_number] => 20240207245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => METHOD FOR INHIBITING METASTASIS OF TRIPLE-NEGATIVE BREAST CANCER USING ROSOXACIN
[patent_app_type] => utility
[patent_app_number] => 18/329895
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329895
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/329895 | METHOD FOR INHIBITING METASTASIS OF TRIPLE-NEGATIVE BREAST CANCER USING ROSOXACIN | Jun 5, 2023 | Pending |
Array
(
[id] => 18769323
[patent_doc_number] => 20230364081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHOD AND FORMULATION FOR TREATING MALE PREMATURE EJACULATION
[patent_app_type] => utility
[patent_app_number] => 18/195416
[patent_app_country] => US
[patent_app_date] => 2023-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18195416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/195416 | METHOD AND FORMULATION FOR TREATING MALE PREMATURE EJACULATION | May 9, 2023 | Abandoned |
Array
(
[id] => 18769343
[patent_doc_number] => 20230364101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => DICLOFENAC PRODRUG AND USE OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/314750
[patent_app_country] => US
[patent_app_date] => 2023-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314750
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/314750 | DICLOFENAC PRODRUG AND USE OF THE SAME | May 8, 2023 | Pending |
Array
(
[id] => 18752332
[patent_doc_number] => 20230355558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => SYSTEM AND METHOD OF DELIVERING INHIBITORS FOR PREVENTING THE ENTRY OF SARS-CoV-2 AND EMERGING VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/143942
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18143942
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/143942 | SYSTEM AND METHOD OF DELIVERING INHIBITORS FOR PREVENTING THE ENTRY OF SARS-CoV-2 AND EMERGING VARIANTS | May 4, 2023 | Abandoned |
Array
(
[id] => 18753878
[patent_doc_number] => 20230357190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => CRYSTALLINE FORMS OF A MAGL INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/311759
[patent_app_country] => US
[patent_app_date] => 2023-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311759
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/311759 | Crystalline forms of a MAGL inhibitor | May 2, 2023 | Issued |
Array
(
[id] => 18737909
[patent_doc_number] => 20230346810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => ENDOGENOUS STABILIZATION OF CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 18/308148
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18308148
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/308148 | ENDOGENOUS STABILIZATION OF CANNABINOIDS | Apr 26, 2023 | Pending |
Array
(
[id] => 18628101
[patent_doc_number] => 20230286926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PROCESS FOR PREPARATION OF TRIAZOLE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/180367
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180367
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180367 | Process for preparation of triazole compound | Mar 7, 2023 | Issued |
Array
(
[id] => 20024856
[patent_doc_number] => 20250163078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/840947
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18840947
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/840947 | IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | Feb 16, 2023 | Pending |
Array
(
[id] => 18860172
[patent_doc_number] => 20230414606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => METHODS OF TREATING PSYCHIATRIC DISORDERS IN OBESE PATIENTS WITH BREXPIPRAZOLE
[patent_app_type] => utility
[patent_app_number] => 18/101340
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101340
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/101340 | METHODS OF TREATING PSYCHIATRIC DISORDERS IN OBESE PATIENTS WITH BREXPIPRAZOLE | Jan 24, 2023 | Abandoned |
Array
(
[id] => 19860662
[patent_doc_number] => 20250099448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/832840
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18832840
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/832840 | HETEROCYCLIC COMPOUNDS | Jan 24, 2023 | Pending |
Array
(
[id] => 19464079
[patent_doc_number] => 20240317748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 18/263592
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263592
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263592 | CARBONYL SUBSTITUTED DIAZASPIRO COMPOUNDS AND ITS USE | Dec 1, 2022 | Pending |